These are the top pharmaceutical stocks selected by JPMorgan for its results
JPMorgan is eyeing some drugmakers ahead of their earnings reports as investors continue to sell shares of major technology companies.…
Health
Discover the Latest Health, Medicine, Nutrition, and Fitness Tips for Women, Men, and Children
How to trade Abbott stock after the nearly $500 million infant formula verdict
Every weekday, the CNBC Investment Club with Jim Cramer hosts a live “Morning Meeting” broadcast at 10:20 a.m. ET. Here's…
Cut 2 stocks and buy 2 other laggards
On Monday morning, we will execute four trades. Shortly after the opening bell, we will sell 100 shares of Danaher…
FDA approves new blood test to detect colon cancer
The Food and Drug Administration approved on Monday 'Guardian Health'The blood test, called Shield, is used to detect colon cancer.…
These drugmakers are catching up to Eli Lilly and Novo Nordisk
The lucrative market for weight-loss drugs won’t be a duopoly forever. With billions at stake, that’s been a virtual guarantee…
Dexcom shares fall more than 40% after second-quarter results
Dexcom Shares fell more than 40% on Friday and were on track for their worst day ever after the diabetes…
A poor earnings report from a competitor is good news for Abbott Labs
Every weekday, the CNBC Investment Club with Jim Cramer hosts a live “Morning Meeting” broadcast at 10:20 a.m. ET. Here’s…
WHO to send 1 million polio vaccines to Gaza to protect children
The Director-General of the World Health Organization (WHO), Tedros Adhanom Ghebreyesus, announced that vaccines will be administered to children in…
Biogen Eisai's Leqembi Alzheimer's drug rejected by EU regulator
European drug regulators on Friday rejected Leqembi's Alzheimer's treatment Biogen and Eisaicreating another hurdle for companies as they struggle to…
Fund manager of names in weight loss and biotechnology
Weight-loss drugs have sparked investor interest and shaken up other sectors over the past year. Novo Nordisk and Eli Lilly…